 | This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (September 2016) |
 | This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Sulfonated phenolics/sulfuric acid" – news · newspapers · books · scholar · JSTOR (January 2011) (Learn how and when to remove this message) |
 | |
| Combination of | |
|---|---|
| Sulfuric acid | Mineral acid |
| Sulfonated phenolics | Sulfonic acid |
| Clinical data | |
| Trade names | Debacterol, Oralmedic |
| Routes of administration | Topical |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| (what is this?) (verify) | |
Sulfonated phenolics/sulfuric acid (brand name Debacterol) liquid topical agent that is used in the treatment of ulcerating oral mucosal lesions and minor oral abrasions.
Description
Sulfonated phenolics/sulfuric acid is used in the treatment of recurrent aphthous stomatitis (canker sores). Debacterol is available as a swab and in a liquid formulation.
Sulfonated phenolics/sulfuric acid is not listed in the Physician's Desk Reference and has not been approved by the Food and Drug Administration for any indication. Debacterol is not an antiseptic or topical anesthetic but rather a chemical cautery agent that destroy cells at the application site, including nerve endings that transmit pain.
Effectiveness
One clinical trial comparing Debacterol to Kenalog-in-Orabase and a no-intervention control group found that patients treated with sulfonated phenolics/sulfuric acid reported significantly better relief of symptoms compared to the other two groups three days after treatment. In the same study, 60 percent of ulcers treated with Debacterol had disappeared by day six compared to about 30 percent in the other treatment groups.
Sulfonated phenolics/sulfuric acid appears to be more effective on sores in areas of the mouth that produce less saliva. Since a sore must be dry prior to application of Debacterol, it is difficult to properly apply under the tongue. The duration of pain relief and the overall effectiveness may be reduced in such areas.
References
- "Debacterol product description".
- "PDR.Net (The Physician's Desk Reference)". www.pdr.net. Retrieved 2018-04-04.
- "Search Results: debacterol". google2.fda.gov. Retrieved 2018-04-04.
- ^ Rhodus NL, Bereuter J (December 1998). "An evaluation of a chemical cautery agent and an anti-inflammatory ointment for the treatment of recurrent aphthous stomatitis: a pilot study". Quintessence International. 29 (12): 769–73. PMID 10196853.
External links
- Debacterol Canker Sore Medication-Product Description
- LABEL: DEBACTEROL CANKER SORE PAIN RELIEF- phenolsulfonic acid and sulfuric acid solution, NCBI DailyMed
- US7132111B2 "Odorless formulation for treating mucosal discontinuities", Google Patents